Authors’ response to comment on “Second‐line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin, and baclofen”

Documenti analoghi

• Second‐line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin and baclofen
  di: Albert Muñoz‐Vendrell, et al.
  Pubblicazione: (2025)
• Comment on “Second‐line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin and baclofen”
  di: Alcántara Montero A
  Pubblicazione: (2025)
• Intravenous magnesium and methocarbamol for acute pain crises in refractory trigeminal neuralgia: A retrospective analysis
  di: Bradley Ong, et al.
  Pubblicazione: (2025)
• The PATCH trial: 5% lidocaine‐medicated plaster for trigeminal neuralgia—Results of a multicentric, enriched enrollment, randomized withdrawal, double‐blind, vehicle‐controlled, parallel‐group study
  di: Chunmei Zhao, et al.
  Pubblicazione: (2024)
• Regulation of headache response and transcriptomic network by the trigeminal ganglion clock
  di: Chorong Han, et al.
  Pubblicazione: (2024)